Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin beta-1 (ITGB1) is a single-chain type I glycoprotein and a member of the integrin family of cell surface receptors. It forms heterodimers with various alpha subunits, resulting in multiple distinct integrins that mediate cell-cell and cell-extracellular matrix (ECM) interactions. These complexes are essential for processes such as embryogenesis, tissue repair, immune response, hemostasis, and cancer metastasis.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin beta 1 subunit (ITGB1).